Skip to main content

Find open calls

Status:
open closed forthcoming

Call identifier Program Deadline / Topic Status Calendar
New Models to Deliver Healthcare 2026

EIT Health

EIT Health

The New Models to Deliver Healthcare (NMDH) Call aims to bridge the gap between proven, market-ready health solutions at Innovation Maturity Level (IML) 8 to 9 and their adoption in real-world healthcare systems. This call offers funding for collaborative, industry-led, payor-supported and patient-centric projects that implement and scale value-based healthcare models.

 

 

2026-05-06T17:00:00
Innovation Validation Call 2026

EIT Health

EIT Health

EIT Health is calling for innovative digital and AI-powered medical technologies that are at an Innovation Maturity Level (IML) 6 and ready for clinical validation and market launch. Selected projects will be awarded funding to run pivotal clinical studies, collect real-world evidence to demonstrate safety and efficacy, apply for regulatory approval, and prepare for market commercialisation.

 

 

2026-05-06T17:00:00
IHI Call 12

IHI

 

2026-04-21T17:00:00
Destination 1 2026

Cluster Health

 

2026-04-16T17:00:00
Destination 6 2026

Cluster Health

HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies (RIA)

The call opens on 10th February 2026

 

2026-04-16T17:00:00
Destination 4 2026

Cluster Health

 

2026-04-16T17:00:00
Destination 3 2026

Cluster Health

 

2026-04-16T17:00:00
Destination 5 2026

Cluster Health

 

2026-04-16T17:00:00
Destination 2 2026

Cluster Health

 

2026-04-16T17:00:00
Joint Transnational Call 2026 for the BE READY Partnership: Advancing knowledge of host and pathogens dynamics to better combat emerging diseases

EP for Pandemic Preparedness

Be Ready


​​

The aim of this call is to increase scientific understanding and evidence-based knowledge on emerging and re-emerging pathogens with pandemic potential as well as on the host responses triggered by infection in order to improve our capacity to anticipate, prevent and respond to infectious health threats through a multinational, collaborative and interdisciplinary approach that bridges research and development. The scope of the call is primarily addressing Priority 1 of the SRIA (Accelerate knowledge in a coordinated and integrative manner), focusing on the proposed Action 1.1 (Increase knowledge on understanding, identifying and addressing therapeutic targets on pathogens) and Action 1.2 (Increase knowledge on pathophysiology).

 

2026-04-13T14:00:00
Female Heart – Clinical Research Grants

Novo Nordisk Foundation

NNF

 

The purpose of the Female Heart – Clinical Research Grants is to enhance clinical understanding of sex-related differences in cardiovascular disease by fostering global collaborative research projects anchored in the Nordics (the main applicant must be anchored and have their primary employment and research group at a university, hospital, or other non-profit research institution in a Nordic country - Denmark, Sweden, Norway, Finland, Iceland)

 

2026-03-19T14:00:00
Fast Track Validation Programme 2026

EP PerMed

The EP PerMed Fast Track Programme 2026 offers targeted support to accelerate the validation and adoption of innovative personalised medicine solutions. The programme helps early-stage innovations progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.

 

2026-03-10T17:00:00
EP Brain Health JTC 2026

EP BrainHealth

EP Brain Health
​​

 

2026-03-10T14:00:00
EDCTP3 RIA call 2026

EDCTP3

 

2026-03-04T17:00:00
Deployment of cutting-edge multi-modal AI-based solutions in medical imaging

Digital Europe Programme

DIGITAL-2026-AI-09-SOLUTIONS-CANCER-STEP

By building on, extending and leveraging the Cancer Image Europe platform, this action is expected to facilitate the uptake of EU AI-driven solutions in medical imaging (including Machine Learning and Generative AI), towards their deployment in clinical settings. It should also include upskilling of healthcare professionals and evidence generation to evaluate the performance of the deployed AI-driven solutions and engage patients.

 

2026-03-03T17:00:00